Trials / Completed
CompletedNCT01444196
Desloratadine 5, 10 and 20mg in Patients With Cold Urticaria
Multi-center, Double Blind, Dose Escalating Study to Compare the Effects of 5 mg, 10mg and 20mg of Desloratadine in Patients With Acquired Cold Urticaria (ACU)
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Marcus Maurer · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of the study is to assess the dosis of DL which is sufficient to inhibit cold urticaria symptoms.
Detailed description
A total of 30 patients (male and female) with ACU will be included in this study
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Desloratadine | Every day,per mouth,in the evening, for 14 +- 2 days. |
Timeline
- Start date
- 2009-08-01
- Primary completion
- 2010-04-01
- Completion
- 2010-05-01
- First posted
- 2011-09-30
- Last updated
- 2011-10-03
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01444196. Inclusion in this directory is not an endorsement.